-
JPM26: Leo Pharma’s growth strategy puts a spotlight on rare dermatology diseases
16 Jan 2026 01:06 GMT
… as exhibited by Leo Pharma’s Anzupgo. While Leo Pharma continues to make its … Ingelheim; under the deal, Leo Pharma will be responsible for commercialisation … diseases and their commercialisation potential.
Leo Pharma’s clinical and commercial experience …
-
JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases
13 Jan 2026 20:37 GMT
Danish dermatology specialist Leo Pharma and its CEO Christophe Bourdon …
-
<![CDATA[Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus]]>
21 Jan 2026 20:32 GMT
… and Chief Scientific Officer of LEO Pharma, in the news release. … this underserved patient population.
References
LEO Pharma advances Anzupgo (delgocitinib) cream to … lichen sclerosus (LS). News release. LEO Pharma. January 21, 2026. Accessed January …
-
LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
07 Jan 2026 12:56 GMT
… partners with insights into LEO Pharma’s innovation strategy, growth … 00 AM PST
About LEO Pharma
LEO Pharma is a global leader … 45 3050 2014
Email:jeilk@leo-pharma.com
KEYWORD: DENMARK EUROPE … TRIALS OTHER HEALTH
SOURCE: LEO Pharma
Copyright Business Wire 2026. …
-
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
16 Dec 2025 10:47 GMT
… the US, and the UK.
LEO Pharma obtained exclusive development and commercialisation … Shionogi holds the rights.
LEO Pharma Development executive vice-president Sophie … label expansion application for Anzupgo, LEO Pharma is reinforcing our commitment aiming …
-
LEO Pharma Appoints Marika Murto to Lead Global Product Strategy
16 Dec 2025 08:45 GMT
… Leadership Team.
Marika joins LEO Pharma from Amgen, where … Murto will join LEO Pharma as Senior Vice President … 45 3050 2014
MailJEILK@leo-pharma.com
KEYWORD: DENMARK EUROPE … RESEARCH SCIENCE PHARMACEUTICAL
SOURCE: LEO Pharma
Copyright Business Wire 2025 …
-
Prevalence of Genital Psoriasis and Its Impact on Patients’ Sexual Life in Routine Care: Epidemiologic Survey in Germany
20 Jan 2026 19:25 GMT
… Company, Formycon, Immunic, Janssen-Cilag, LEO Pharma, MetrioPharm, Merck, Sharp & Dohme … , Eli Lilly, Galderma, Hexal, Janssen, LEO Pharma, Medac, Mylan B.V., Novartis …
-
LEO Pharma receives NICE approval for chronic hand eczema cream
10 Nov 2025 13:55 GMT
LEO Pharma has received Technology Appraisal Guidance ( … at LEO Pharma,” said Leanne Walsh, Vice President and General Manager, LEO Pharma UK …
-
LEO Pharma Delivers 8% Revenue Growth at CER in 9M 2025 and Updates Full-Year Outlook
06 Nov 2025 08:50 GMT
… with Boehringer Ingelheim closed, granting LEO Pharma global development and commercialization rights … for generalized pustular psoriasis. Leveraging LEO Pharma’s global dermatology platform, the … (1,262)
N.m.
About LEO Pharma
LEO Pharma is a global leader in …
-
LEO Pharma Strengthens Leadership in Medical Dermatology with the Appointment of Sophie Lamle as Chief Development Officer
03 Nov 2025 12:01 GMT
… strengthening LEO Pharma's Search & Development model.
Sophie joins LEO Pharma from … of the Innovation Committee.
About LEO Pharma
LEO Pharma is a global leader in … CLINICAL TRIALS OTHER HEALTH
SOURCE: LEO Pharma
Copyright Business Wire 2025.
PUB …
About
© 1995-2026